https://www.clinrol.com/study/619
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers | Clinrol
IMGN151-1001 is a Phase 1 study assessing safety, tolerability, and preliminary antitumor activity in adults with various recurrent cancers.
first in humangynaecological cancersstudyrecurrent